CompletedNot Applicable

Parameters of Acceptability, Compliance and Efficacy of Fulvestrant in Post-menopausal Patients With Advance Breast Cancer

Argentina500 participantsStarted 2009-04

Plain-language summary

The objectives of this study is to obtain information of Faslodex use in the treatment of breast cancer in the clinical practice in Argentina.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Postmenopausal women with hormone receptor-positive locally advanced or metastatic breast cancer with recurrence during or after adjuvant anti-estrogen therapy or disease progression during anti-estrogen treatment, currently receiving Faslodex * Signature of the informed consent Exclusion Criteria: * Any contraindication to Faslodex administration

What they're measuring

To collect real life data of acceptability and compliance on the use of Faslodex in the Argentine population.

Timeframe: monthly

To collect real life data of efficacy on the use of Faslodex in the Argentine population.

Timeframe: monthly

Trial details

NCT IDNCT00878930

SponsorAstraZeneca

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2010-12

View on ClinicalTrials.gov More Breast Cancer trials